We are live on ! Find out more
MWVC

Morgens Waterfall Vintiadis & Co Portfolio holdings

AUM $81.2M
1-Year Est. Return 86.87%
This Fund
S&P 500
This Quarter Est. Return
+0.87%
1 Year Est. Return
+86.87%
3 Year Est. Return
+484.3%
5 Year Est. Return
+875.12%
10 Year Est. Return
+12,893.79%
AUM
$107M
AUM Growth
-$40.5M
Cap. Flow
-$36.9M
Cap. Flow %
-34.62%
Top 10 Hldgs %
52.72%
Holding
56
New
6
Increased
4
Reduced
18
Closed
26

Top Buys

Rank Stock Value
1
COST icon
Costco
COST
+$3.64M
2
AAPL icon
Apple
AAPL
+$3.24M
3
NKE icon
Nike
NKE
+$2.98M
4
MLNX
Mellanox Technologies, Ltd.
MLNX
+$2.35M
5
FRPT icon
Freshpet
FRPT
+$2.31M

Top Sells

Rank Stock Value
1
CZR icon
Caesars Entertainment
CZR
+$4.77M
2
TTWO icon
Take-Two Interactive
TTWO
+$4.62M
3
AMD icon
Advanced Micro Devices
AMD
+$4.59M
4
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$4.36M
5
PARA
Paramount Global Class B
PARA
+$3.69M

Sector Composition

Rank Sector Weight
1 Technology 48.09%
2 Consumer Discretionary 19.4%
3 Communication Services 12.24%
4 Consumer Staples 9.41%
5 Financials 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
V icon
26
Visa
V
$677B
$1.14M 1.07%
7,100
-5,800
-45% -$1.09M
RETA
27
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$866K 0.81%
6,000
-22,600
-79% -$4.36M
MA icon
28
Mastercard
MA
$493B
$773K 0.72%
3,200
-3,300
-51% -$981K
AZN icon
29
AstraZeneca
AZN
$250B
$500K 0.47%
5,600
-850
-13% -$80K
JPM icon
30
JPMorgan Chase
JPM
$950B
$350K 0.33%
3,893
-682
-15% -$82.9K
ADMA icon
31
ADMA Biologics
ADMA
$2.22B
– –
-600,000
Closed -$2.4M
AGIO icon
32
Agios Pharmaceuticals
AGIO
$1.93B
– –
-21,000
Closed -$1M
AMD icon
33
Advanced Micro Devices
AMD
$789B
– –
-100,000
Closed -$4.59M
BA icon
34
Boeing
BA
$185B
– –
-1,500
Closed -$489K
BP icon
35
BP
BP
$107B
– –
-12,532
Closed -$473K
CLLS
36
Cellectis
CLLS
$285M
– –
-17,000
Closed -$291K
CRSP icon
37
CRISPR Therapeutics
CRSP
$5.17B
– –
-10,000
Closed -$609K
CZR icon
38
Caesars Entertainment
CZR
$6.14B
– –
-80,000
Closed -$4.77M
EDIT icon
39
Editas Medicine
EDIT
$442M
– –
-15,000
Closed -$444K
ESPR
40
DELISTED
Esperion Therapeutics
ESPR
– –
-20,000
Closed -$1.19M
HRTX icon
41
Heron Therapeutics
HRTX
$92.9M
– –
-50,000
Closed -$1.18M
ILMN icon
42
Illumina
ILMN
$28.4B
– –
-5,140
Closed -$1.66M
LH icon
43
Labcorp
LH
$25.9B
– –
-6,518
Closed -$947K
LULU icon
44
PUT
lululemon athletica
LULU
$14.6B
– –
-14,000
Closed -$3.24M
MDT icon
45
Medtronic
MDT
$112B
– –
-15,000
Closed -$1.7M
MRK icon
46
Merck
MRK
$318B
– –
-6,540
Closed -$568K
NBIX icon
47
Neurocrine Biosciences
NBIX
$16.6B
– –
-9,000
Closed -$967K
PARA
48
DELISTED
Paramount Global Class B
PARA
– –
-88,000
Closed -$3.69M
TMO icon
49
Thermo Fisher Scientific
TMO
$220B
– –
-5,000
Closed -$1.62M
TTWO icon
50
Take-Two Interactive
TTWO
$46.1B
– –
-37,700
Closed -$4.62M
1
2
3

Similar funds

SPW
Sonoma Private Wealth Sonoma, California $81.2M AUM 22.25% 1-Year Est. Return
MC
Medici Capital Newport Beach, California $81.2M AUM 76.04% 1-Year Est. Return
FPAM
Feynman Point Asset Management New York $81.1M AUM
QM
QVIDTVM Management The Woodlands, Texas $81.4M AUM 2.94% 1-Year Est. Return
AGFVA
Accel Growth Fund V Associates Palo Alto, California $81.7M AUM 29.05% 1-Year Est. Return
HM
HCEP Management Hong Kong $80.7M AUM 1.24% 1-Year Est. Return
BCM
Bayesian Capital Management Brooklyn, New York $81.9M AUM 26.59% 1-Year Est. Return
KL
Khall LLC San Francisco, California $82M AUM

Morgens Waterfall Vintiadis & Co's Q1 2020 Portfolio in Review

As of Q1 2020, Morgens Waterfall Vintiadis & Co held 56 positions worth $107M, down 28% from $147M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Morgens Waterfall Vintiadis & Co withdrew a net $36.9M in Q1 2020, closing 26 positions and reducing 18 holdings. Its most notable exit was Caesars Entertainment, an estimated $4.77M position sold in full.

By sector, the portfolio is most concentrated in Technology at 48% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Morgens Waterfall Vintiadis & Co opened a new position in Costco worth $3.42M.

  • Morgens Waterfall Vintiadis & Co's largest Q1 2020 buy was Costco: 12,000 shares worth $3.42M.
  • Morgens Waterfall Vintiadis & Co added most to Meta Platforms (Facebook) in Q1 2020, an estimated $450K increase.
  • Morgens Waterfall Vintiadis & Co's biggest Q1 2020 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $4.36M.
  • Morgens Waterfall Vintiadis & Co fully exited Caesars Entertainment in Q1 2020, selling an estimated $4.77M.
  • Morgens Waterfall Vintiadis & Co's ten largest holdings make up 53% of its $107M portfolio in Q1 2020.
  • Morgens Waterfall Vintiadis & Co opened 6 new positions and closed 26 in Q1 2020.
  • Morgens Waterfall Vintiadis & Co's portfolio value fell 28% quarter-over-quarter to $107M.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q1 2020, filed 15 May 2020.